+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Avastin"

From
From
From
From
US Glioma - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

US Glioma - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • April 2023
  • 200 Pages
  • United States
From
Bevacizumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Bevacizumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 125 Pages
  • Global
From
From
From
From
From
Avastin (bevacizumab; Genentech/Roche/Chugai) Drug Overview 2019 - Product Thumbnail Image

Avastin (bevacizumab; Genentech/Roche/Chugai) Drug Overview 2019

  • Drug Pipelines
  • March 2019
  • 111 Pages
  • Global
Colorectal Cancer Forecast and Market Analysis to 2036 - Product Thumbnail Image

Colorectal Cancer Forecast and Market Analysis to 2036

  • Report
  • September 2018
  • 630 Pages
  • Global
From
Colorectal Cancer KOL Interview - UK - Product Thumbnail Image

Colorectal Cancer KOL Interview - UK

  • Newsletter
  • April 2024
  • 14 Pages
  • United Kingdom
Colorectal Cancer KOL Interview - US, Northeast - Product Thumbnail Image

Colorectal Cancer KOL Interview - US, Northeast

  • Newsletter
  • April 2024
  • 14 Pages
  • United States
Loading Indicator

Avastin is a drug used in the treatment of certain types of cancer. It is a monoclonal antibody that works by blocking the growth of new blood vessels that tumors need to grow. Avastin is used to treat a variety of cancers, including colorectal, lung, kidney, and ovarian cancer. It is also used to treat metastatic breast cancer. Avastin is administered intravenously and is often used in combination with other cancer treatments, such as chemotherapy and radiation therapy. Avastin is a key drug in the oncology market, as it is used to treat a variety of cancers. It is one of the most widely used cancer drugs in the world, and is often used in combination with other treatments. Avastin is a valuable tool in the fight against cancer, as it can help slow the growth of tumors and prolong the lives of patients. Some of the companies in the Avastin market include Roche, Merck, Pfizer, AstraZeneca, and Novartis. Show Less Read more